Except for the historical information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in the Forest Laboratories’ Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any subsequent SEC filings.

Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of the applicable webcast. The Company does not undertake to update any of these statements in light of new information or future events. The continued posting by the Company of a webcast is not a republication thereof or reiteration of the statements made therein.